ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "B cells"

  • 2021 American Transplant Congress

    Intrarenal B-cell Activating Factor (BAFF) Levels are Increased in Transplant Glomerulopathy

    S. Panzer, K. Swanson, G. Pandya, L. Hidalgo, S. Reese

    University of Wisconsin Madison, Madison, WI

    *Purpose: Transplant glomerulopathy (TG), a key feature of chronic active antibody-mediated rejection (caABMR), is associated with allograft failure. B-cell activating factor (BAFF) is a cytokine…
  • 2021 American Transplant Congress

    Evaluation of Rituximab-abbs in Renal Transplant: A Case Series

    A. Dao1, B. Jimenez2, A. Reyad1, J. Guiteau1, M. Madhrira3, N. Umezurike1, S. Patel1, S. Allam3

    1Transplant, Medical City Fort Worth, Fort Worth, TX, 2College of Pharmacy, University of North Texas, Fort Worth, TX, 3Tarrant Nephrology Associates, Premier Physicians Group Health, Fort Worth, TX

    *Purpose: Biosimilars are FDA-approved alternatives to cost-prohibitive biologics, with no clinically meaningful differences in safety, purity, and potency. Rituximab-abbs, a biosimilar to rituximab, has labeled…
  • 2021 American Transplant Congress

    Contribution of T-bet Expressing CD27+ CD21- Activated Memory B Cells Poised for Plasma Cell Differentiation to Antibody-mediated Rejection of Kidney Transplants

    K. Louis1, E. Bailly1, C. Macedo1, B. Ramaswami1, X. Gu1, G. Chalasani1, A. Zeevi1, P. Randhawa1, H. Singh2, C. Lefaucheur3, D. Metes1

    1Surgery, University of Pittsburgh, Pittsburgh, PA, 2Center for Systems immunology, Department of Immunology, University of Pittsburgh, Pittsburgh, PA, 3Human Immunology and Immunopathology, INSERM U976, Paris, France

    *Purpose: Alloimmunity triggered by donor-specific antibodies (DSAs) and ensuing development of antibody-mediated rejection (ABMR) are detrimental to organ transplants. Yet, the cellular states underlying B…
  • 2021 American Transplant Congress

    TOLS are Novel Regulatory TLOs with A B Cell Signature

    I. Rosales1, Q. Yuan1, C. Yang1, P. Russell1, J. Madsen1, A. Alessandrini1, R. Colvin1, -. AA and RC2

    1Massachusetts General Hospital, Boston, MA, 2Co-Senior Authors, Boston, MA

    *Purpose: Our previous studies suggest that a DBA/2 kidney graft is accepted by a MHC-fully mis-matched C57/BL6 recipient. Accepted renal allografts exhibited lymphoid like structures…
  • 2021 American Transplant Congress

    CD40 Blockade by the Fc-Silent Immunosuppressive Antibody Iscalimab Results in Diminished B Cell Activation and Differentiation and is Paralleled by Whole Blood Gene Expression Data

    R. Kraaijeveld1, M. W. van den Hoogen1, A. E. de Weerd1, E. Ferroro2, G. Robert2, U. Laessing2, B. Haraldsson2, J. S. Rush2, C. C. Baan1

    1Erasmus MC, Rotterdam, Netherlands, 2Novartis Pharmaceuticals AG, Basel, Switzerland

    *Purpose: Blockade of costimulatory molecule CD40 by the Fc-silent immunosuppressive drug Iscalimab has shown to inhibit acute alloreactivity in non-human primates and is currently being…
  • 2021 American Transplant Congress

    Belatacept and Carfilzomib-based Treatment of Active Antibody-mediated Rejection in a Sensitized Nonhuman Primate Model

    J. Kwun1, R. Schmitz1, M. Manook1, Z. Fitch1, D. Olaso1, A. Choi1, J. Yoon1, Y. Bae1, J. Lambris2, S. Knechtle1

    1Surgery, Duke University, Durham, NC, 2Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

    *Purpose: One third of sensitized, HLA-incompatible transplant recipients experience antibody-mediated rejection (AMR) with limited effective treatment options. We tested a novel treatment strategy for AMR…
  • 2021 American Transplant Congress

    Single Cell RNA Sequencing of Tim1- B Cells and Tim1+ Regulatory B Cells

    Q. Fu1, K. Lee2, K. Deng2, D. Agarwal3, P. v. Galen4, C. G. Rickert2, G. Huai2, H. Yang1, C. LeGuern2, S. Deng1, J. F. Markmann2

    1Organ Transplantation Center, Sichuan Provincial People's Hospital, University of Electronic Sciences and Technology of China, Chengdu, China, 2Center for Transplantation Sciences, MGH, Boston, MA, 3Division of Transplantation, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, 4Division of Hematology, Brigham and Women's Hospital, Boston, MA

    *Purpose: Tim1 signaling has an important role in inducing and maintaining the function of Regulatory B cells. Our previous study showed that Tim1+ Bregs prolong…
  • 2021 American Transplant Congress

    Belatacept and Rapamycin Maintenance Immunosuppression in a Sensitized Nonhuman Primate Kidney Allotransplantation Model

    R. Schmitz1, Z. W. Fitch1, M. Manook1, J. Yoon1, A. B. Farris2, J. Kwun1, S. J. Knechtle1

    1Department of Surgery, Duke University Medical Center, Durham, NC, 2Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA

    *Purpose: Desensitization with costimulation blockade and proteasome inhibition prior to kidney transplantation prevents early antibody-mediated rejection (AMR) and prolongs graft survival in highly sensitized nonhuman…
  • 2021 American Transplant Congress

    Lung Transplant Recipients Developing Early DSAs are Characterized by a Shift Towards Memory B Cells Directly After Transplantation

    S. Christoph1, A. Hitz1, R. Bellmàs Sanz1, J. Kühne1, B. Wiegmann2, F. Ius2, J. Salman2, E. Chichelnitskiy1, T. Siemeni2, W. Sommer3, A. Haverich2, G. Warnecke3, C. Falk1

    1Institute of Transplant Immunology, MHH, Hannover, Germany, 2Department of Cardiothoracic, Transplant and Vascular Surgery, MHH, Hannover, Germany, 3Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany

    *Purpose: After lung transplantation (LTx), the development of early donor HLA-specific antibodies (eDSA) is associated with antibody-mediated rejection (AMR) and poor graft survival. Since 2013,…
  • 2021 American Transplant Congress

    Properties of Regulatory B Cells Suppressing B Cells

    Q. Fu1, K. Lee2, K. Deng2, G. Huai2, C. Rickert2, H. Yang1, C. LeGuern2, S. Deng1, J. F. Markmann2

    1Organ Transplantation Center, Sichuan Provincial People's Hospital, University of Electronic Sciences and Technology of China, Chengdu, China, 2Center for Transplantation Sciences, MGH, Boston, MA

    *Purpose: Our previous study showed that TLR-Bregs, regulatory B cells generated in vitro through TLR activation, suppressed naïve B cell proliferation triggered by a mitogen…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 35
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences